Search
forResearch 10 of 1000+
- Safety Profile and Efficacy of Biosea® Revive Serum for Hair Growth Through In Vitro Assessment and Clinical Evaluation
- Safety Evaluation of Topical Valproate Application
- Safety Evaluation of a Hair Regrowth Tonic Containing Swertia Extract
- LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study
- An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects
- Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation
- Drug safety evaluation of exemestane
- Evaluating safety and ethical implications of androgenetic alopecia treatments: a comparison of direct-to-consumer platforms and dermatologist visits
- 15485 Evaluating the safety and efficacy of intense pulsed light with radiofrequency in US patients with hidradenitis suppurativa: A split-body study
- Clinical evaluation of the efficacy and safety of ‘ThriveCo anti-dandruff pre-shampoo treatment,’ containing ZenscalpinTM in the management of scalp dandruff in healthy adults
Community 10 of 282
- PP405 is still being evaluated for safety over efficacy.
- PP405 2a study was a safety study. Some rational explaining.
- Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA
- Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study
- Kintor long term safety phase 3
- Effectiveness and Safety of Hair Growth Formulation Containing Tectona grandis L.f (Teak) Leaf Extract
- KX-826: Long-Term Safety Results are out!
- 2.5mg dut safety/price/synergy w/topical fin
- How can I safely apply RU58841 whilst I have children in the house?
- How to safely stop topical finasteride?